Published on 28 February 2022

BMclinical’s experts put together a document with the top selling products so far of 2022 and a hybrid sourcing case study.

Top Selling Products of 2022
Pharmaceutical companies invest a large proportion of their R&D budget in the procurement of commercial drugs for their clinical trials and drug development research. We have complied our top selling pharmaceuticals so far in 2022. This list is based on our own activities within the market.

Case Study: Hybrid Sourcing
BMclinical received a large-scale request for proposal (RFP) from a sponsor for Stelara (ustekinumab) broken down into three purchases across 2021. Find out how we used a hybrid sourcing method to handle this request by reading the case study.

Can’t open the document? Please click here.